Abstract
In this issue of Blood, in a series of elegant studies in a transplantable mouse model of acute myeloid leukemia (AML), Hossain et al1 show that systemic signal transducer and activator of transcription 3 (STAT3) blocking/TLR9 triggering can eradicate established AML through an immune-mediated mechanism.
Cite
CITATION STYLE
APA
Rezvani, K., & Barrett, J. (2014, January 2). STAT3: The “achilles” heel for AML? Blood. American Society of Hematology. https://doi.org/10.1182/blood-2013-11-537092
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free